课题基金 / 基金详情

Longitudinal assessment of immune-tumor interactions during lung cancer progression

Longitudinal assessment of immune-tumor interactions during lung cancer progression
肺癌进展过程中免疫-肿瘤相互作用的纵向评估
批准号：
322453
负责人：
Lockwood William W
金额：
$51.29万
依托单位：
BC Cancer, part of PHSA (Vancouver)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-03-01 至 2020-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=322453&lang=en
关键词：
Biomarkers Chemoprevention Cytokines Early Detection Immune Response Immunomodulation Lung Cancer Mouse Models

项目摘要

项目成果

Lockwood William W的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The poor prognosis for lung cancer (LC) patients is typically associated with a late stage of disease at the time of diagnosis, highlighting the need for effective methods for early detection. Recently, it has been demonstrated that low-dose computed tomo
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SNF2 Histone Linker PHD RING Helicase as a novel tumor suppressor gene and risk factor in lung adenocarcinoma development
Understanding the effects of ERK hyperactivation in cancer: implications for therapy
The effects of smoking marijuana on lung cancer development: implications for screening and early detection.
  • 批准号：
    410491
  • 项目类别：
    Operating Grants
  • 资助金额：
    $50.16万
  • 财政年份：
    2019
  • 负责人：
    Lockwood William W
  • 依托单位：
    BC Cancer, part of PHSA (Vancouver)
Developing agonistic therapeutic strategies for lung cancer based on synthetic lethal oncogene interactions
  • 批准号：
    345188
  • 项目类别：
    Operating Grants
  • 资助金额：
    $55.69万
  • 财政年份：
    2016
  • 负责人：
    Lockwood William W
  • 依托单位：
    BC Cancer, part of PHSA (Vancouver)
海外基金